These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Remoxipride in the treatment of levodopa-induced psychosis. Sandor P; Lang AE; Singal S; Angus C J Clin Psychopharmacol; 1996 Oct; 16(5):395-9. PubMed ID: 8889913 [TBL] [Abstract][Full Text] [Related]
6. [Toxic and adverse neurological effects of anti-parkinsonian drugs]. Sunohara N Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):527-31. PubMed ID: 10434715 [No Abstract] [Full Text] [Related]
7. 'Bad guys' among the antiparkinsonian drugs. Pirtosek Z Psychiatr Danub; 2009 Mar; 21(1):114-8. PubMed ID: 19270634 [TBL] [Abstract][Full Text] [Related]
8. Use of clozapine to treat levodopa-induced psychosis in Parkinson's disease: retrospective review. Widman LP; Burke WJ; Pfeiffer RF; McArthur-Campbell D J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):63-6. PubMed ID: 9188021 [TBL] [Abstract][Full Text] [Related]
9. Clozapine prevents recurrence of psychosis in Parkinson's disease. Factor SA; Brown D Mov Disord; 1992; 7(2):125-31. PubMed ID: 1350059 [TBL] [Abstract][Full Text] [Related]
10. [Neuromuscular disorders due to adverse effects of antiparkinson agents]. Hattori N Nihon Naika Gakkai Zasshi; 2007 Aug; 96(8):1614-20. PubMed ID: 17802710 [No Abstract] [Full Text] [Related]
11. Treatment of drug-induced psychosis in Parkinson's disease with clozapine. Greene P; Cote L; Fahn S Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214 [No Abstract] [Full Text] [Related]
12. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences]. Drach LM Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015 [TBL] [Abstract][Full Text] [Related]
13. Understanding Parkinson's disease: an update on current diagnostic and treatment strategies. Pahwa R J Am Med Dir Assoc; 2006 Sep; 7(7 Suppl 2):4-10. PubMed ID: 17948613 [TBL] [Abstract][Full Text] [Related]
14. Drugs for Parkinson's disease. Treat Guidel Med Lett; 2011 Jan; 9(101):1-6; quiz 2 p following 6. PubMed ID: 21304446 [No Abstract] [Full Text] [Related]
15. Drugs for Parkinson's disease. Treat Guidel Med Lett; 2013 Nov; 11(135):101-6. PubMed ID: 24165688 [TBL] [Abstract][Full Text] [Related]
16. Dopamine dysregulation syndrome with psychosis in 24-hour intestinal levodopa infusion for Parkinson's disease. Ricciardi L; Espay KJ; Krikorian R; Fasano A; Espay AJ Parkinsonism Relat Disord; 2016 Jul; 28():152-4. PubMed ID: 27086263 [No Abstract] [Full Text] [Related]
17. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia. Reddy S; Factor SA; Molho ES; Feustel PJ Mov Disord; 2002 Jul; 17(4):676-81. PubMed ID: 12210856 [TBL] [Abstract][Full Text] [Related]
18. Managing psychosis in patients with Parkinson's disease. Cummings JL N Engl J Med; 1999 Mar; 340(10):801-3. PubMed ID: 10072418 [No Abstract] [Full Text] [Related]
19. Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease. Factor SA; Molho ES; Brown DL J Neuropsychiatry Clin Neurosci; 1995; 7(3):304-7. PubMed ID: 7580188 [TBL] [Abstract][Full Text] [Related]
20. Melperone in the treatment of iatrogenic psychosis in Parkinson's disease. Barbato L; Monge A; Stocchi F; Nordera G Funct Neurol; 1996; 11(4):201-7. PubMed ID: 8934152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]